Scientists have discovered who can protect against cancer with regular aspirin

Taking aspirin may protect against colorectal cancer in people at risk. This was shown by a study published in the journal JAMA Oncology, reports
gazeta.ru.

Scientists analyzed data from 107 thousand patients. The 10-year incidence of colorectal cancer was 1.98% in the regular aspirin group and 2.95% among others. Regular use of aspirin was defined as taking a specific dose of the drug.

Those who led the most unhealthy lifestyles benefited the most from the drug. For them, the risk of colorectal cancer was 3.4% if they did not take aspirin and 2.12% if they did. This means that taking aspirin could prevent one in 78 cases of colorectal cancer in the unhealthy lifestyle group over 10 years. Those who led a healthy lifestyle had the least benefit. Taking aspirin could only prevent one in 909 cases of colorectal cancer.

Previous studies have shown that aspirin prevents colorectal cancer through several mechanisms. Therefore, the United States recommended daily low-dose aspirin to prevent cardiovascular events and colorectal cancer for all people aged 50 to 59 years. This recommendation was suspended in 2016 due to concerns that aspirin increases the risk of gastrointestinal bleeding.